ArticleEJNMMI research2026
Preoperative assessment of IDH status in adult glioma by integrated
Article in EJNMMI research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundTo investigate the diagnostic value of PET/MR fusion images for the noninvasive prediction of IDH status using various fusion strategies.
methodsThis retrospective study involved 45 patients with histopathologically confirmed gliomas who underwent preoperative integrated 18F-FET PET/MR from May 2023 to August 2024. Image fusion was performed by combining PET and the IVIM-derived α map using three commonly used fusion algorithms: discrete wavelet transform (DWT), Laplacian pyramid (LP), and ratio-of-low-pass pyramid (RP). PET parameters and first-order histogram features were extracted from 18F-FET PET, IVIM α map, and fused images. A support vector machine (SVM) classifier with a radial basis function (RBF) kernel was used for classification. Model performance was evaluated through stratified cross-validation, with the area under the receiver operating characteristic curve (AUC) as the main metric.
resultsAll three fusion-based models outperformed single-modality models and the combined model baseline. Specifically, the LP-based fusion model showed an improved AUC of 0.790 (95% CI: 0.783-0.798); the RP-based fusion model achieved the highest AUC of 0.820 (95% CI: 0.813-0.828); and the DWT-based fusion model reached an AUC of 0.814 (95% CI: 0.806-0.821), with the highest sensitivity at 0.747. Additionally, the parameter analyses demonstrated that the fusion performance was highly sensitive to the weighting strategy across frequency bands. Optimized fusion weights are critical to realize the full benefit of PET/MR image fusion.
conclusionIntegrated ¹⁸F-FET PET/MR image fusion offers a promising alternative to traditional multimodal analysis. Its application in individualized treatment and precision medicine is highly promising.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.